pRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2187-2192

  Cenci, Maria ^a   Pisani, Tiziana ^b   French, Deborah ^b   Alderisio, Mauro ^c   Vecchione, Aldo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cervical cancer; HPV; Immunohistochemistry; p107; p53; pRb2 p130

Indexed keywords

ANTIBODY; PARAFFIN; PROTEIN P107; PROTEIN P130; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 21344444575     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parkin DM, Bray FI and Davesi S: Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-S66, 2000.
2. Shneider V, Henry MR, Jimenez-Ayala M, Turnbull LS and Carr Wright T: Cervical cancer screening errors and reporting. Acta Cytol 45: 493-498, 2001.
3. Cenci M and Vecchione A: Atypical squamous and glandular cells of undetermined significance (ASCUS and AGUS) of the uterine cervix (Review). Anticancer Res 20: 3701-3708, 2000.
4. Feichter G and Meisels A: Task force consensus report on HPV-related changes of the lower female genital tract. Acta Cytol 46: 630-632, 2002.
5. Cenci M, French D, Pisani T, Alderisio M, Lombardi AM, Marchese R, Colelli F and Vecchione A: p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy. Anticancer Res 23: 1385-1387, 2003.
6. French D, Cermele C, Vecchione A, Cenci M and Vecchione A: HPV infection and microsatellite instability in squamous lesions of the uterine cervix. Anticancer Res 20: 3417-3422, 2000.
7. Paggi MG, Baldi A, Bonetto F and Giordano A: Retinoblastoma protein family in cell cycle and cancer (Review). J Cell Biochem 62: 418-430, 1996.
8. Paggi MG and Giordano A: Who is the boss in the Retinoblastoma family? The point of view of Rb2/p130, the little brother (Review). Cancer Res 61: 4651-4654, 2001.
9. Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG, Caputi M, Baldi F and Giordano G: Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin Cancer Res 3: 1691-1697, 1997.
10. Caputi M, Groeger AM, Esposito V, De Luca A, Maciullo V, Mancini A, Baldi F, Wolner E and Giordano A: Loss of oRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer. Clin Cancer Res 8: 3850-3856, 2002.
11. Tanaka N, Ogi K, Odajima T, Dehari H, Yamada S, Sonoda T and Kohama G: pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma. Cancer 92: 2117-2125, 2001.
12. Zamparelli A, Masciullo V, Bovicelli A, Santini D, Ferrandina G, Minimo C, Terzano P, Costa S, Cinti C, Ceccarelli C, Mancuso S, Scambia G, Bovicelli L and Giordano A: Expression of cell-cycle-associated proteins pRb2/p130 and p27kip1 in vulvar squamous cell carcinomas. Hum Pathol 32: 4-9, 2001.
13. Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A and Cardi G: Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27kip1, p53, mdm2, and Ki-67 (MIB-I) in prostatic gland adenocarcinoma. Clin Cancer Res 8: 1808-1815, 2002.
14. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
15. Hickman ES, Moroni MC and Helin K: The role of p53 and pRb in apoptosis and cancer (Review). Curr Opin Oncol 12: 60-66, 2002.
16. Skomedal H, Kristensen GB, Lie KL and Holm R: Aberrant expression of the cell cycle associated proteins TP53, mdm2, p21, p27, CDK4, cyclin D1, Rb, and EGFR in cervical carcinomas. Gynecol Oncol 73: 223-228, 1999.
17. Busby-Earle RMC, Steel CM, Williams ARW, Cohen B and Bird CC: p53 mutations in cervical cancerogenesis. Low frequency and lack of correlation with human papillomavirus status. Br J Cancer 69: 732-737, 1994.
18. Lambkin HA, Mothershill CM and Kelehan P: Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 172: 13-18, 1994.
19. Vecchione A, Cermele C, Giovagnoli MR, Valli C, Alimandi M, Carico E, Esposito DL, Mariani-Costatini R and French D: p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 55: 343-348, 1994.
20. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuers J, Leigh IM, Matlashewski G and Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 21: 229-234, 1998.
21. Giarnieri E, Mancini R, Pisani T, Alderisio M and Vecchione A: Msh2, mlh1, Fhit, p53, Bcl-2, and bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res 6: 3600-3606, 2000.
22. van Muyden RCPA, ter Harmsel BWA, Smedts FMM, Hermans J, Kuijpers JC, Raikhlin NT, Petrov S, Lebedev A, Ramaekers FCS, Trimbos JB, Kleter B and Quint WG: Detection and typing of human papillomavirus in cervical carcinomas in Russian women. Cancer 85: 2011-2016, 1999.
23. Milde-Langosch K, Riethdorf S and Loning T: Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions. Theoretical and practical implications. Virchows Arch 437: 227-233, 2000.
24. Slagle BL, Kaufman RH, Reeves WC and Icenogle JP: Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia. Cancer 83: 1401-1408, 1998.
25. Battifora H: p53 immunohistochemistry. A word of caution (Editorial). Hum Pathol 25: 435-437, 1994.
26. Tjalma GC, Weyler JJ, Bogers JJ, Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van Mark EA and Buytaert PM: The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 97: 223-230, 2001.
27. Kersemaekers AMF, Fleuren GJ, Kenter GG, van den Broek LJCM, Ulijie SM, Hermans J and van de Vijver MJ: Oncogene alterations in carcinomas of the uterine cervix. Overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5: 577-586, 1999.
28. Troncone G, Martinez JC, Palombini L, De Rosa G, Mugica C, Rodriguez JA, Zeppa P, Di Vizio D, Lucariello A and Piris MA: Immunohistochemical expression of mdm2 and p21 in invasive cervical cancer. Correlation with p53 protein and high risk HPV infection. J Clin Pathol 51: 754-760, 1998.
29. Grace VMB, Shalini JV, Sree lekha TT, Devaraj SN and Devaraj H: Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 91: 51-58, 2003.
30. Koyamatsu Y, Yokoyama M, Nakao Y, Fukuda K, Saito T, Matsukuma K and Iwasaka T: A comparative analysis of human papillomavirus types 6 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol 90: 547-551, 2003.
31. Ziol M, Di Tomaso C, Biaggi A, Tepper M, Piquet P, Carbillon L, Uzan M and Guettier C: Virological and biological characteristics of cervical intraepithelial neoplasia grade I with marked koilocytotic atypia. Hum Pathol 29: 1068-1073, 1998.
32. Giannoudis A and Herrington CS: Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomavirus. Cancer 89: 1300-1307, 2000.
33. Mathevet P, Frappat L and Hittelman W: Expression of p53 and pRb in cervical dysplasia. Correlation with mitotic activity. Gynecol Obstet Fertil 1: 44-50, 2000.
34. Lie K, Solvi S, Skomedal H, Haugen OA and Holm R: Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection. Int J Gynecol Pathol 18: 5-11, 1999.
35. Vojesek B, Bartek J, Midgley CA and Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. J Immunol Methods 151: 237-244, 1992.
36. Lepik D, Ilves I, Kristjuhan A, Maimets T and Ustav M: p53 protein is a suppressor of papillomavirus DNA amplificational replication. J Virol 72: 6822-6831, 1998.
37. Seavey SE, Holubar M, Saucedo LJ and Perry ME: The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19ARF. J Virol 73: 7590-7598, 1999.
38. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PP: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
39. Carrilho C, Gouveia P, Cantel M, Alberto M, Buane L and David L: Characterization of human papillomavirus infection, p53 and Ki-67 expression in cervix cancer of Mozambican women. Pathol Res Pract 199: 303-311, 2003.
40. Bar Jk, Harlozinska A, Sedlaczek P, Kasiak J and Martowska J: Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias. Anticancer Res 21: 1001-1006, 2001.